Seminar with the CMDE on New IVD and NGS Technologies
2016-08-30 | Beijing, Shanghai
High-level researchers from the R&D centres of member companies presented on new technologies for detection and assessment of treatment results of cancer. The presentations focussed on
- biomarkes in oncology
- Liquid Biopsy Technologies
- NGS-based Test and Services
China has become the country with most cancer patients in the world. Manufactures are encouraged to strengthen R&D and bring the newest products on the Chinese market. At the same time regulators should accelarate market approval to avoid delayed access to life-saving technologies for Chinese patients.